Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024. In the quarter to June 2026, revenue grew 5.15%, EPS fell 920.0%, free cash flow grew 28.6% and total debt fell 25.1%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five.

54.80 1.74 −3.08%
Market cap
$8.6B
P/E
0.0×
Fwd P/E
55.7×
Dividend yield
0.36%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.43 2.08 1.59 2.62
P/FCF ratio
347.32 105.01 72.24 77.21
P/Operating CF
(148.55) 31.12 77.21 (118.42)
P/B ratio
2.01 2.89 2.23 3.82
Price to Tangible BV
0.00 272.95 0.00 89.33
EV/Sales
1.93 2.54 2.03 3.09
EV/EBITDA
23.82 30.23 25.60 54.16
EV/Operating CF
70.49 65.04 50.15 56.75
EV/FCF
468.13 128.07 92.45 91.03
Quick Ratio
0.67 0.66 0.50 0.61
Current Ratio
1.85 1.73 1.55 1.85
Net Debt/EBITDA
439.85 11.68 22.45 (224.64)
Debt/Assets
31.21% 29.95% 27.26% 30.15%
Debt/Equity
0.82 0.76 0.68 0.76
Asset Turnover
0.55 0.57 0.57 0.56
Operating CF/Net income
0.53 15.42 20.34 1.23
Capex/Depreciation
(0.38) (0.39) (0.42) (0.50)
Research and Development Expense of Revenue
11.42% 10.19% 12.30% 11.25%
Selling, General and Administrative Expense of Revenue
28.18% 25.30% 29.40% 28.49%
Intangible Assets out of Total Assets
0.38 0.39 0.40 0.38
Share Based Compensation of Revenue
0.00% 2.07% 0.00% 0.00%
Graham Net Nets
(0.33) (0.22) (0.28) (0.16)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(0.49%) (0.32%) (0.66%) (1.16%)
Free Cash Flow Yield
0.29% 0.95% 1.38% 1.30%
Revenue per Share
5.67 6.44 5.41 5.51
Operating CF per Share
(0.22) 1.51 0.47 (0.51)
Capex per Share
(0.14) (0.15) (0.16) (0.19)
Free Cash Flow per Share
(0.36) 1.37 0.31 (0.70)
Cash per Share
1.93 1.97 0.88 1.21
Shareholders Equity per Share
16.14 16.29 16.21 15.76
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
16.14 16.29 16.21 15.76
Free Cash Flow
(54.10) 207.20 47.00 (106.20)
Working Capital
1,082.50 933.30 748.50 1,020.30
Capital Expenditures
(20.90) (22.60) (24.20) (28.80)
Net Current Asset Value
(1,634.80) (1,555.40) (1,560.10) (1,427.70)
EV/EBIT
103.87 127.88 150.97 0.00
Capex to Sales
0.02 0.02 0.03 0.03
Price to Operating Income
77.06 104.86 117.97 0.00
Other line items
Average Receivables
544.65 555.20 540.25 534.25
Average Payables
205.95 225.00 256.85 221.60
Average Inventory
1,208.50 1,081.20 1,119.00 1,169.20
Average Assets
6,273.90 6,024.05 6,031.90 6,196.35
Average Common Equity
2,137.30 2,135.30 2,149.95 2,109.80

Fold the line items

Columns are period end dates